Program Expansion Supplement: Supporting Laboratory Strengthening Activities in Resource-Limited Countries under the President's Emergency Plan for AIDS Relief (PEPFAR)

The summary for the Program Expansion Supplement: Supporting Laboratory Strengthening Activities in Resource-Limited Countries under the President's Emergency Plan for AIDS Relief (PEPFAR) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Centers for Disease Control CGH, which is the U.S. government agency offering this grant.
Program Expansion Supplement: Supporting Laboratory Strengthening Activities in Resource-Limited Countries under the President's Emergency Plan for AIDS Relief (PEPFAR): The President’s Emergency Plan for AIDS Relief (PEPFAR) has called for immediate, comprehensive and evidence based action to turn the tide of global HIV/AIDS. As called for by the PEPFAR Reauthorization Act of 2008, initiative goals over the period of 2009 through 2013 are to treat at least three million HIV infected people with effective combination anti-retroviral therapy (ART); care for twelve million HIV infected and affected persons, including five million orphans and vulnerable children; and prevent twelve million infections worldwide (3,12,12). To meet these goals and build sustainable local capacity, PEPFAR will support training of at least 140,000 new health care workers in HIV/AIDS prevention, treatment and care. The Emergency Plan Five-Year Strategy for the five year period, 2009 - 2014 is available at the following Internet address: http://www.pepfar.gov. The overarching purpose of this FOA is to fund activities to prevent or control disease or injury and improve health, or to improve a public health program or service. ASCP may not use funds for research. Certain activities that may require human subjects review due to institutional requirements but that are generally considered not to constitute research (e.g., formative assessments, surveys, disease surveillance, program monitoring and evaluation, field evaluation of diagnostic tests, etc.) may be funded through this mechanism. Under the leadership of the U.S. Global AIDS Coordinator, as part of the President's Emergency Plan, the U.S. Department of Health and Human Services’ Centers for Disease Control and Prevention (HHS/CDC) works with host countries and other key partners to assess the needs of each country and design a customized program of assistance that fits within the host nation's strategic plan and partnership framework. HHS/CDC focuses primarily on two or three major program areas in each country. Goals and priorities include the following: Achieving primary prevention of HIV infection through activities such as expanding confidential counseling and testing programs linked with evidence based behavioral change and building programs to reduce mother-to-child transmission; Improving the care and treatment of HIV/AIDS, sexually transmitted infections (STIs) and related opportunistic infections by improving STI management; enhancing laboratory diagnostic capacity and the care and treatment of opportunistic infections; interventions for intercurrent diseases impacting HIV infected patients including tuberculosis (TB); and initiating programs to provide anti-retroviral therapy (ART); Strengthening the capacity of countries to collect and use surveillance data and manage national HIV/AIDS programs by expanding HIV/STI/TB surveillance programs and strengthening laboratory support for surveillance, diagnosis, treatment, disease monitoring and HIV screening for blood safety; and Developing, validating and/or evaluating public health programs to inform, improve and target appropriate interventions, as related to the prevention, care and treatment of HIV/AIDS, TB and opportunistic infections. In an effort to ensure maximum cost efficiencies and program effectiveness, HHS/CDC also supports coordination with and among partners and integration of activities that promote Global Health Initiative principles. As such, grantees may be requested to participate in programmatic activities that include the following activities: Implement a woman- and girl-centered approach; Increase impact through strategic coordination and integration; Strengthen and leverage key multilateral organizations, global health partnerships and private sector engagement; Encourage country ownership and invest in country-led plans; Build sustainability through investments in health systems; Improve metrics, monitoring and evaluation; and Promote research, development and innovation (research is not supported by this FOA). The provision of quality laboratory services and the conduct of reliable diagnostic testing are challenging in many international settings where resources are limited. Quality laboratory testing is an integral element of the clinical diagnosis scheme, infectious disease surveillance, and the formation of public health policy. Good laboratory practices prove to be cost-effective, promote reliable and accurate results, contribute to good patient care, and promote a positive attitude towards testing from a patient’s perspective.
Federal Grant Title: Program Expansion Supplement: Supporting Laboratory Strengthening Activities in Resource-Limited Countries under the President's Emergency Plan for AIDS Relief (PEPFAR)
Federal Agency Name: Centers for Disease Control CGH (HHS-CDC-CGH)
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: CDC-RFA-GH13-13660301SUPP16
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.067
CFDA Descriptions: Information not provided
Current Application Deadline: October 22nd, 2016
Original Application Deadline: October 22nd, 2016
Posted Date: August 23rd, 2016
Creation Date: August 23rd, 2016
Archive Date: November 21st, 2016
Total Program Funding: $500,000
Maximum Federal Grant Award: $500,000
Minimum Federal Grant Award: $0
Expected Number of Awards: 1
Cost Sharing or Matching: No
Last Updated: August 23rd, 2016
Applicants Eligible for this Grant
Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility
Eligible entities for this announcement are listed below: American Society for Clinical Pathology
Grant Announcement Contact
Priyanka Rathod
wnv9@cdc.gov

Grants Policy
Similar Government Grants
Provision of Expanded High Quality HIV/STIs Prevention, Care, and Treatment Services in Tr...
Strengthening HIV Strategic Information Activities in the Republic of Senegal under the Pr...
Supporting Implementation of HIV and TB Services for Epidemic Control in the Republic of M...
Advancing National Public Health Institutes Globally
To Support the Uganda Ministry of Health to Execute its Core Mandate for a Harmonized and ...
Expansion and Support of HIV/AIDS/STI/TB Information, Education, and Communication and Beh...
Increasing Access to HIV Counseling and Testing (VCT) and Enhancing HIV/AIDS Communication...
Cooperative Agreement for Global Capacity through Internation NGO Partnership
More Grants from the Centers for Disease Control CGH
Provision of Expanded High Quality HIV/STIs Prevention, Care, and Treatment Services in Tr...
Strengthening HIV Strategic Information Activities in the Republic of Senegal under the Pr...
Strengthening Public Health Laboratories Internationally
Emergency Response and Recovery Branch (ERRB) Supplemental Emergency Component
Supporting Implementation of HIV and TB Services for Epidemic Control in the Republic of M...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2019 FederalGrants.com